Last Chance to Register for the Johnson & Johnson Innovation Digital Health Masterclass

Over 100 of Europe's best digital health companies have already asked to take part in the Johnson & Johnson Digital Health Masterclass and an impressive line up of some of Europe's foremost experts in healthcare, technology, business strategy and venture capital is in place to help companies deliver on their growth agenda.

Executives from the selected digital health companies will have the opportunity to enjoy the benefits of a growth-focused curriculum, expert advice, and close interaction with venture and angel financing partners. Launched in July, in partnership with Health 2.0, the Masterclass offers an opportunity for executives to take their businesses to the next level and to raise their profile with key influencers in the field of digital health.

The programme modules will include:

Session 1, Berlin - September 18th to 20th 2013

  • Clear evidence-based case for healthcare transformation and digital health
  • Detailed look at G5 Healthcare markets & innovation programmes
  • Examination of regulatory issues and compliance for digital health companies
  • Strategy Exercise- identifying core capabilities required to maintain strategic advantage

Session 2, Barcelona - October 9th to 11th 2013

  • Business model development, excercise, and expert review
  • Developing detailed growth-focused business models and related operational plans
  • Deep dive on technology and trends in each of the primary Digital Health technology verticals
  • Introduction on scaling business operations

Session 3, London - October 28th to 30th 2013

  • Scaling product and service delivery
  • Developing trials and data sets to support "evidence based" sales
  • Building executive teams, boards, and advisors that can help you scale
  • Power of Story- build a powerful company story that connects with investors and customers
  • Financing your company's growth

The programme will culminate in an Investor Day on November 20th in London, run in partnership with local venture capitalists, healthcare providers and technology companies, the day will also provide significant networking opportunities. All companies will be able to meet and to forge their own relationships directly with prospective investors and customers.

9th of August is the closing date for applications - successful applicants will not only have the opportunity to share a prize pool of €50k, they will also have a rare chance to interact with leading voices from business, healthcare, and technology.

Format: Companies selected for the Masterclass will attend a series of three 3-day workshops run in partnership with local healthcare and technology companies. Networking sessions will be held in the evening at each location

Dates: September 18th to November 20th

Workshops: European locations, finishing in London.

Challenge and Investor Day, London - 20th November 2013 in association with Health 2.0 Europe

For further information, please visit:
http://masterclass.jnjinnovation.com

Related news article:

Most Popular Now

ChatGPT can Produce Medical Record Notes…

The AI model ChatGPT can write administrative medical notes up to ten times faster than doctors without compromising quality. This is according to a new study conducted by researchers at...

Alcidion and Novari Health Forge Strateg…

Alcidion Group Limited, a leading provider of FHIR-native patient flow solutions for healthcare, and Novari Health, a market leader in waitlist management and referral management technologies, have joined forces to...

Can Language Models Read the Genome? Thi…

The same class of artificial intelligence that made headlines coding software and passing the bar exam has learned to read a different kind of text - the genetic code. That code...

Study Shows Human Medical Professionals …

When looking for medical information, people can use web search engines or large language models (LLMs) like ChatGPT-4 or Google Bard. However, these artificial intelligence (AI) tools have their limitations...

Advancing Drug Discovery with AI: Introd…

A transformative study published in Health Data Science, a Science Partner Journal, introduces a groundbreaking end-to-end deep learning framework, known as Knowledge-Empowered Drug Discovery (KEDD), aimed at revolutionizing the field...

Bayer and Google Cloud to Accelerate Dev…

Bayer and Google Cloud announced a collaboration on the development of artificial intelligence (AI) solutions to support radiologists and ultimately better serve patients. As part of the collaboration, Bayer will...

Shared Digital NHS Prescribing Record co…

Implementing a single shared digital prescribing record across the NHS in England could avoid nearly 1 million drug errors every year, stopping up to 16,000 fewer patients from being harmed...

Ask Chat GPT about Your Radiation Oncolo…

Cancer patients about to undergo radiation oncology treatment have lots of questions. Could ChatGPT be the best way to get answers? A new Northwestern Medicine study tested a specially designed ChatGPT...

Wanted: Young Talents. DMEA Sparks Bring…

9 - 11 April 2024, Berlin, Germany. The digital health industry urgently needs skilled workers, which is why DMEA sparks focuses on careers, jobs and supporting young people. Against the backdrop of...

North West Anglia Works with Clinisys to…

North West Anglia NHS Foundation Trust has replaced two, legacy laboratory information systems with a single instance of Clinisys WinPath. The trust, which serves a catchment of 800,000 patients in North...

Can AI Techniques Help Clinicians Assess…

Investigators have applied artificial intelligence (AI) techniques to gait analyses and medical records data to provide insights about individuals with leg fractures and aspects of their recovery. The study, published in...

AI Makes Retinal Imaging 100 Times Faste…

Researchers at the National Institutes of Health applied artificial intelligence (AI) to a technique that produces high-resolution images of cells in the eye. They report that with AI, imaging is...